Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by Updownsidewayson Jul 09, 2018 9:11pm

78 Views

Post# 28290759

RE:Predictions

.14 is the general bottom, but I picked up my previous lot at .13 last time we were down here. I have now another bid waiting at .13 again. If you’re patient, bid on .13 or .135 and put your order good for as long as you can. But if you need shares now, line up and bid .14 or slap the lowest ask you can get.

DatAssBandit wrote:
Who thinks this thing is going to tank down to 0.14 for the week? 0.14 seems like the current bottom based on the last couple months movement. I feel like it's a good price to buy/add and then flip for small gains.

Bullboard Posts

Fortuna reports record earnings for Q3 2024